Key points are not available for this paper at this time.
Artificial intelligence (AI) has emerged as a transformative force in regenerative medicine, revolutionizing research, clinical applications, and personalized therapies. This article explores how AI accelerates the identification of biomarkers, optimizes cell and tissue engineering processes, and enhances treatment efficacy through personalized medicine approaches. AI's role in predictive analytics, robotic systems for tissue fabrication, and real-time monitoring tools underscores its potential to reshape the future of healthcare. Addressing ethical considerations is essential as AI continues to pave the way for innovative regenerative therapies.
Tamadon et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: